News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BYBEE CLINTON
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/15/2022 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 5,000,000 shares
@ $1.5, valued at
$7.5M
Bought 5,000,000 warrants
@ $1.875, valued at
$9.4M
|
|
| 09/07/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 196,003 shares
@ $0
Disposed of 253,997 shares
@ $0
Acquired 11,763 shares
@ $0
Acquired 1,338 shares
@ $0
Acquired 2,662 shares
@ $0
Disposed of 239,559 shares
@ $0
Disposed of 310,441 shares
@ $0
Acquired 14,383 shares
@ $0
Acquired 1,624 shares
@ $0
Acquired 3,248 shares
@ $0 |
|
| 09/01/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0 |
|
| 08/26/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0 |
|
| 08/22/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0 |
|
| 08/16/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0
Disposed of 217,781 shares
@ $0 |
|
| 06/10/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 1,475 shares
@ $0
Acquired 2,952 shares
@ $0 |
|
| 06/06/2022 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,076 shares
@ $0
Acquired 4,426 shares
@ $0 |
|
| 12/22/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 762,233 shares
@ $0
Disposed of 987,767 shares
@ $0
Acquired 45,703 shares
@ $0
Acquired 15,504 shares
@ $0 |
|
| 12/01/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,057 shares
@ $0
Acquired 4,428 shares
@ $0 |
|
| 11/24/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 13,057 shares
@ $0
Acquired 4,428 shares
@ $0 |
|
| 07/06/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 1,742,248 shares
@ $0
Disposed of 2,257,752 shares
@ $0
Acquired 25,279 shares
@ $0
Acquired 8,133 shares
@ $0 |
|
| 07/02/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Disposed of 200,000 shares
@ $0
Disposed of 200,000 shares
@ $0
Acquired 2,555 shares
@ $0
Acquired 811 shares
@ $0
Acquired 4,686 shares
@ $0 |
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 435,562 shares
@ $0
Disposed of 564,438 shares
@ $0
Acquired 6,320 shares
@ $0
Acquired 2,028 shares
@ $0 |
|
| 06/23/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Converted 18,206,358 shares
@ $0
Converted 17,771,216 convertible preferred
@ $0
Converted 435,142 convertible preferred
@ $0 |
|
| 06/16/2021 |
3
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 3 on Lyell Immunopharma, Inc. |
| 04/15/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Disposed of 75,000 shares
@ $0
Disposed of 75,000 shares
@ $0
Acquired 958 shares
@ $0
Acquired 306 shares
@ $0 |
|
| 04/09/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 3,161 shares
@ $0
Acquired 1,019 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 3,161 shares
@ $0
Acquired 1,019 shares
@ $0 |
|
| 04/02/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Disposed of 200,000 shares
@ $0
Disposed of 200,000 shares
@ $0
Acquired 2,555 shares
@ $0
Acquired 811 shares
@ $0 |
|
| 04/01/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 3,160 shares
@ $0
Acquired 1,014 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 3,160 shares
@ $0
Acquired 1,016 shares
@ $0 |
|
| 03/22/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Disposed of 200,000 shares
@ $0
Disposed of 200,000 shares
@ $0
Acquired 2,553 shares
@ $0
Acquired 810 shares
@ $0
Disposed of 200,000 shares
@ $0
Disposed of 200,000 shares
@ $0
Acquired 2,555 shares
@ $0
Acquired 813 shares
@ $0 |
|
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/12/2021 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Disposed of 75,000 shares
@ $0
Disposed of 75,000 shares
@ $0
Acquired 958 shares
@ $0
Acquired 306 shares
@ $0 |
|
| 12/22/2020 |
4
| ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on 908 Devices Inc.|
Txns:
| Converted 5,425,045 shares
@ $0
Bought 300,000 shares
@ $20, valued at
$6M
Converted 2,927,386 preferred shares
@ $0
Converted 981,443 preferred shares
@ $0
Converted 669,977 preferred shares
@ $0
Converted 665,661 preferred shares
@ $0
Converted 180,578 preferred shares
@ $0 |
|
| 12/17/2020 |
3
| ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 3 on 908 Devices Inc. |
| 11/24/2020 |
4
| ARCH VENTURE FUND VI LP (10% Owner) has filed a Form 4 on Quanterix Corp|
Txns:
| Disposed of 229,006 shares
@ $0
Disposed of 145,994 shares
@ $0
Acquired 854 shares
@ $0
Acquired 853 shares
@ $0
Disposed of 277,514 shares
@ $0
Disposed of 176,920 shares
@ $0
Acquired 1,034 shares
@ $0
Acquired 1,036 shares
@ $0 |
|
| 11/16/2020 |
4
| ARCH Venture Partners IX, LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Disposed of 75,000 shares
@ $0
Disposed of 75,000 shares
@ $0
Acquired 958 shares
@ $0
Acquired 306 shares
@ $0 |
|
| 10/23/2020 |
4
| BYBEE CLINTON (Director) has filed a Form 4 on IMPINJ INC|
Txns:
| Exercised 3,411 restricted stock units
@ $0 |
|
| 10/20/2020 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Converted 1,784,572 shares
@ $0
Converted 831,521 shares
@ $0
Converted 420,368 shares
@ $0
Converted 326,953 shares
@ $0
Converted 191,721 shares
@ $0
Bought 235,000 shares
@ $15, valued at
$3.5M
Converted 13,950,000 preferred shares
@ $0
Converted 6,500,000 preferred shares
@ $0
Converted 3,000,000 preferred shares
@ $0
Converted 2,333,333 preferred shares
@ $0
Converted 1,320,097 preferred shares
@ $0 |
|
| 10/13/2020 |
3
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on Codiak BioSciences, Inc. |
| 09/22/2020 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Converted 1,960,784 shares
@ $0
Converted 472,251 shares
@ $0
Converted 138,734 shares
@ $0
Bought 210,000 shares
@ $13, valued at
$2.7M
Converted 138,734 shares
@ $0
Bought 20,000 shares
@ $13, valued at
$260k
Converted 1,960,784 convertible preferred
@ $0
Converted 472,251 convertible preferred
@ $0
Converted 138,734 convertible preferred
@ $0
Converted 138,734 convertible preferred
@ $0 |
|
| 09/15/2020 |
3
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on Metacrine, Inc. |
|
|
|